Literature DB >> 14693966

Low synthesis and high absorption of cholesterol characterize type 1 diabetes.

Tatu A Miettinen1, Helena Gylling, Juha Tuominen, Piia Simonen, Veikko Koivisto.   

Abstract

OBJECTIVE: Streptozotocin-induced type 1 diabetes in experimental animals inhibits cholesterol synthesis and increases cholesterol absorption. In contrast to human type 2 diabetes, virtually no information is available on cholesterol synthesis and absorption in type 1 diabetes. RESEARCH DESIGN AND METHODS: We studied the variables of cholesterol metabolism in 27 patients with type 1 diabetes and in 10 patients with type 2 diabetes matched for body weight, using cholesterol precursor sterol ratios to cholesterol as surrogate markers of synthesis, and those of cholestanol and plant sterols of cholesterol absorption. Glucose control was good in all subjects.
RESULTS: Total and HDL cholesterol and LDL triglycerides were higher in type 2 than in type 1 diabetes. Serum sterols, measured also in VLDL, intermediate-density lipoprotein (IDL), LDL, and HDL, were transported up to >90% by LDL and HDL in type 1 diabetes. The ratios of all absorption sterols in serum and in each lipoprotein were higher, and those of the synthesis markers, especially cholestenol and lathosterol, were lower in type 1 than in type 2 diabetes.
CONCLUSIONS: In contrast to type 2 diabetes, the findings in type 1 diabetes could be related to low expression of ABC G/5 G/8 genes, resulting in high absorption of cholesterol and sterols in general and low synthesis of cholesterol.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14693966     DOI: 10.2337/diacare.27.1.53

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  14 in total

Review 1.  Diabetic dyslipidemia and cardiovascular risk.

Authors:  Robert H Eckel
Journal:  Curr Diab Rep       Date:  2008-12       Impact factor: 4.810

2.  Type 1 diabetes is associated with an increase in cholesterol absorption markers but a decrease in cholesterol synthesis markers in a young adult population.

Authors:  Ivana Semova; Amy E Levenson; Joanna Krawczyk; Kevin Bullock; Kathryn A Williams; R Paul Wadwa; Amy S Shah; Philip R Khoury; Thomas R Kimball; Elaine M Urbina; Sarah D de Ferranti; Franziska K Bishop; David M Maahs; Lawrence M Dolan; Clary B Clish; Sudha B Biddinger
Journal:  J Clin Lipidol       Date:  2019-09-25       Impact factor: 4.766

3.  Insulin sensitivity regulates cholesterol metabolism to a greater extent than obesity: lessons from the METSIM Study.

Authors:  Helena Gylling; Maarit Hallikainen; Jussi Pihlajamäki; Piia Simonen; Johanna Kuusisto; Markku Laakso; Tatu A Miettinen
Journal:  J Lipid Res       Date:  2010-05-01       Impact factor: 5.922

Review 4.  Cholesterol absorption: influence of body weight and the role of plant sterols.

Authors:  Helena Gylling; Tatu A Miettinen
Journal:  Curr Atheroscler Rep       Date:  2005-11       Impact factor: 5.113

5.  Do plant sterol concentrations correlate with coronary artery disease in type 1 diabetes? A report from the Pittsburgh Epidemiology of Diabetes Complications Study.

Authors:  Christina Marie Shay; Rhobert Wyn Evans; Trevor John Orchard
Journal:  J Diabetes       Date:  2009-06       Impact factor: 4.006

6.  Insulin Prevents Hypercholesterolemia by Suppressing 12α-Hydroxylated Bile Acids.

Authors:  Ivana Semova; Amy E Levenson; Joanna Krawczyk; Kevin Bullock; Mary E Gearing; Alisha V Ling; Kathryn A Williams; Ji Miao; Stuart S Adamson; Dong-Ju Shin; Satyapal Chahar; Mark J Graham; Rosanne M Crooke; Lee R Hagey; David Vicent; Sarah D de Ferranti; Srividya Kidambi; Clary B Clish; Sudha B Biddinger
Journal:  Circulation       Date:  2022-02-23       Impact factor: 39.918

7.  Body mass index and glycemic control influence lipoproteins in children with type 1 diabetes.

Authors:  Shalini Vaid; Lynae Hanks; Russell Griffin; Ambika P Ashraf
Journal:  J Clin Lipidol       Date:  2016-08-06       Impact factor: 4.766

Review 8.  Dyslipidemia and diabetes: reciprocal impact of impaired lipid metabolism and Beta-cell dysfunction on micro- and macrovascular complications.

Authors:  Gianluca Bardini; Carlo M Rotella; Stefano Giannini
Journal:  Rev Diabet Stud       Date:  2012-11-15

9.  Hepatic insulin receptor deficiency impairs the SREBP-2 response to feeding and statins.

Authors:  Ji Miao; Joel T Haas; Praveen Manthena; Yanning Wang; Enpeng Zhao; Bhavapriya Vaitheesvaran; Irwin J Kurland; Sudha B Biddinger
Journal:  J Lipid Res       Date:  2014-02-10       Impact factor: 5.922

10.  De novo lipogenesis and cholesterol synthesis in humans with long-standing type 1 diabetes are comparable to non-diabetic individuals.

Authors:  Jennifer E Lambert; Edmond A Ryan; Alan B R Thomson; Michael T Clandinin
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.